There is a potential for integrating other imaging modalities in the management of pancreatic cancer.
Standard uptake values from 18F-FLT PET images have been shown to correlate with cellular proliferation in some malignancies.
18F-FLT PET in GI malignancies is limited by high physiologic radiotracer uptake in surrounding normal tissues and liver.
18F-FLT PET has higher specificity but lower sensitivity compared to 18F-FDG PET for measurement of cellular proliferation.
Dynamic imaging with 18F-FLT PET allows an improved understanding of treatment effects and detection of liver metastases.